The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia

Acta Neuropathologica

Volumn 120, Issue 2, 2010, Pages 131-143

  Schulz Schaeffer, Walter J ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Synuclein; Dendritic spines; Neurodegeneration; Protein aggregates; Synapse

Indexed keywords

ALPHA SYNUCLEIN; NEUROTRANSMITTER;

CELL DEATH; DEGENERATIVE DISEASE; DENDRITIC SPINE; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; HUMAN; NERVE FIBER REGENERATION; NEURAL STEM CELL TRANSPLANTATION; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRESYNAPTIC NERVE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; SUBSTANTIA NIGRA; ANIMAL; BRAIN; METABOLISM; PATHOLOGY; SYNAPSE;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; LEWY BODY DISEASE; PARKINSON DISEASE; SYNAPSES;

EID: 77957264418     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-010-0711-0     Document Type: Review

References (157)

1. Akopian AN, Wood JN (1995) Peripheral nervous systemspecific genes identified by subtractive cDNA cloning. J Biol Chem 270:21264-21270
2. Al-Wandi A, Ninkina N, Millership S, Williamson SJ, Jones PA, Buchman VL (2010) Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice. Neurobiol Aging 31:796-804
3. Andreoletti O, Simon S, Lacroux C et al (2004) PrPSc accumulation in myocytes from sheep incubating natural scrapie. Nat Med 10:591-593 (Pubitemid 38796849)
4. Aoki. C, Mahadomrongkul V, Fujisawa S, Habersat R, Shirao T (2007) Chemical and morphological alterations of spines within the hippocampus and entorhinal cortex precede the onset of Alzheimer's disease pathology in double knock-in mice. J Comp Neurol 505:352-362 (Pubitemid 350134058)
5. Aoki C, Sekino Y, Hanamura K et al (2005) Drebrin A is a postsynaptic protein that localizes in vivo to the submembranous surface of dendritic sites forming excitatory synapses. J Comp Neurol 483:383-402 (Pubitemid 40315394)
6. Baba M, Nakajo S, Tu PH et al (1998) Aggregation of alphasynuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879-884 (Pubitemid 28173348)
7. Baglioni S, Casamenti F, Bucciantini M et al (2006) Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci 26:8160-8167
8. Beach TG, Adler CH, Lue L et al (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613-634
9. Beach TG, White CL, Hamilton RL et al (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116:277-288
10. Belichenko PV, Brown D, Jeffrey M, Fraser JR (2000) Dendritic and synaptic alterations of hippocampal pyramidal neurones in scrapie-infected mice. Neuropathol Appl Neurobiol 26:143-149
11. Bergeron C, Petrunka C, Weyer L, Pollanen MS (1996) Altered neurofilament expression does not contribute to Lewy body formation. Am J Pathol 148:267-272 (Pubitemid 26019661)
12. Bouzamondo-Bemstein E, Hopkins SD, Spilman P et al (2004) The neurodegeneration sequence in prion diseases: evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol 63:882-899
13. Braak H, Del TK, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211 (Pubitemid 36007810)
14. Brundin P, Li JY, Holton JL, Lindvall O, Revesz T (2008) Research in motion: the enigma of Parkinson's disease pathology spread. Nat Rev Neurosci 9:741-745
15. Bucciantini M, Calloni G, Chiti F et al (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem 279:31374-31382
16. Bucciantini M, Giannoni E, Chi ti F et al (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507-511
17. Bucciantini M, Rigacci S, Berti. A et al (2005) Patterns of cell death triggered in two different cell lines by HypF-N prefibrillar aggregates. FASEB J 19:437-439 (Pubitemid 40316542)
18. Cabin DE, Shimazu K, Murphy D et al (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22:8797-8807 (Pubitemid 35379049)
19. Chandra S, Fornai F, Kwon HB et al (2004) Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci USA 101:14966-14971
20. Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123:383-396
21. Clavaguera F, Bolmont T, Crowther RA et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909-913
22. Clayton DF, George JM (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21:249-254
23. Conway KA, Harper JD, Lansbury PT Jr (2000) Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39:2552-2563
24. Davenport HA, Combs CM (1954) Golgi's dichromate-silver method. 3. Chromating fluids. Stain Technol 29:165-173
25. Davies CA, Mann, DM, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78:151-164
26. Day M, Wang Z, Ding J et al (2006) Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9:251-259
27. Desplats P, Lee HJ, Bae EJ et al (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106:13010-13015
28. Deutch AY (2006) Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson's disease. J Neural Transm Suppl (70):67-70
29. Dickson DW, Fujishiro H, DelleDonne A et al (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 115:437-444
30. Ding TT, Lee SJ, Rochet JC, Lansbury PT Jr (2002) Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. Biochemistry 41:10209-10217
31. DiRosa G, Puzzo D, Sant'Angelo A, Trinchese F, Arancio O (2003) Alpha-synuclein: between, synaptic function and dysfunction. Histol Histopathol 18:1257-1266
32. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-272
33. Fortin DL, Nemani VM, Voglmaier SM, Anthony MD, Ryan TA, Edwards RH (2005) Neural activity controls the synaptic accumulation of alpha-synuclein. J Neurosci 25:10913-10921 (Pubitemid 41692621)
34. Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH (2004) Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci 24:6715-6723
35. Fujiwara H, Hasegawa M, Dohmae N et al (2002) alphaSynuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160-164
36. Gai WP, Power JH, Blumbergs PC, Blessing WW (1998) Multiple-system atrophy: a new alpha-synuclein disease? Lancet 352:547-548
37. Galvin JE, Pollack J, Morris JC (2006) Clinical phenotype of Parkinson disease dementia. Neurology 67:1605-1611
38. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33-39
39. George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361-372
40. Ghetti B, Piccardo P, Spillantini MG et al (1996) Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci. USA 93:744-748
41. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol. Neurosurg Psychiatry 51:745-752
42. Goers J, Manning-Bog AB, McCormack AL et al (2003) Nuclear localization of alpha-synuclein and its interaction with histones. Biochemistry 42:8465-8471 (Pubitemid 36875412)
43. Gomez-Isla T, Growdon WB, McNamara M et al (1999) Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies. Neurology 53:2003-2009
44. Gomez-Tortosa E, Irizarry MC, Gomez-Isla T, Hyman BT (2000) Clinical and neuropathological correlates of dementia with Lewy bodies. Ann NY Acad Sci 920:9-15 (Pubitemid 32056546)
45. Gomez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT (1999) Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology 53:12841291
46. Gubellini P, Picconi B, Di FM, Calabresi P (2010) Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia; from experimental models to neurodegenerative diseases. Biochim Biophys Acta 1802:151-161
47. Harding AJ, Broe GA, Halliday GM (2002) Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125:391-403
48. Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355-363
49. Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 125:2431-2445 (Pubitemid 35303503)
50. Hardy JA, Dodd PR, Oakley AE, Kidd AM, Perry RH, Edwardson JA (1982) Use of post-mortem human synaptosomes for studies of metabolism and transmitter amino acid release. Neurosci Lett 33:317-322
51. Haycock JW (1993) Polyvinylpyrrolidone as a blocking agent in immunochemical studies. Anal Biochem 208:397-399
52. Hill WD (1996) Altered neurofilament expression does not contribute to Lewy body formation. Am J Pathol 149:728-729
53. Hornykiewi.cz O (2008) Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness. Neurodegener Dis 5:114117
54. Huttner WB, Schiebler W, Greengard P, De CP (1983) Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol 96:1374-1388
55. Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095-1097
56. Ingham CA, Hood SH, Arbuthnott GW (1989) Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res 503:334-338
57. Iwai A, Masliah E, Yoshimoto M et al (1995) The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467-475
58. Iwatsubo T, Yamaguchi H, Fujimuro M et al (1996) Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 148:1517-1529
59. Jakes R, Spillantini MG, Goedert M (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345:27-32
60. Jankovic J (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368-376
61. Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y (1990) Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience 38:245-253
62. Jeffrey M, Halliday WG, Bell J et al (2000) Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol 26:41-54 (Pubitemid 30145305)
63. Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111:1219-1235
64. Jellinger KA (2008) A critical reappraisal, of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116:1-16
65. Ji H, Liu YE, Jia T et al (1997) Identification of a breast cancerspecific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 57:759-764
66. Jo E, Darabie AA, Han K, Tandon A, Eraser PE, McLaurin J (2004) alpha-Synuclein-synaptosomal membrane interactions: implications for flbrillogenesis. Eur J Biochem 271:3180-3189 (Pubitemid 38998687)
67. Kahle PJ, Neumann M, Ozmen L et al (2001) Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol 159:2215-2225
68. Kitamoto T, Shin RW, Doh-ura K et al (1992) Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 140:1285-1294
69. Kobayashi C, Aoki C, Kojima N, Yamazaki H, Shirao T (2007) Drebrin a content correlates with spine head size in the adult mouse cerebral, cortex. J Comp Neurol 503:618-626 (Pubitemid 47184580)
70. Kontopoulos E, Parvin JD, Feany MB (2006) Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet 15:3012-3023
71. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14:504-506
72. Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB (2008) Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 23:2303-2306
73. Kordower JH, Freeman TB, Snow BJ et al (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124
74. Kovacs GG, Puopolo M, Ladogana A et al (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166-174
75. Kramer ML, Behrens C, Schulz-Schaeffer WJ (2008) Selective detection, quantification, and subcellular location of alphasynuclein aggregates with a protein, aggregate filtration assay. Biotechniques 44:403-411.
76. Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic alphasynuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27:1405-1410 (Pubitemid 46255421)
77. Kruger R, Kuhn W, Muller T et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18:106-108
78. Lacroux C, Simon S, Benestad SL et al (2008) Prions in milk from ewes incubating natural scrapie. PLoS Pathog 4:e1000238
79. Langsten JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980
80. Langsten JW, Sastry S, Chan P, Forno LS, Bolin LM, Di Monte DA (1998) Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease. Exp Neurol 154:684-690
81. Lansbury PT Jr (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci USA 96:3342-3344
82. Lee HJ, Lee SJ (2002) Characterization of cytoplasmic alphasynuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J Biol. Chem 277:4897648983
83. Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25:6016-6024 (Pubitemid 40911433)
84. Lee HJ, Suk JE, Bae EJ, Lee JH, Paik SR, Lee SJ (2008) Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Biol 40:1835-1849
85. Lezmi S, Bencsik A, Baron T (2006) PET-blot analysis contributes to BSE strain recognition in C57B1/6 mice. J Histochem Cytochem 54:1087-1094 (Pubitemid 44434712)
86. Li JY, Englund E, Holton JL et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-tograft disease propagation. Nat Med. 14:501-503
87. Libow LS, Frisina PG, Haroutunian V, Perl DP, Purohit DP (2009) Parkinson's disease dementia: a diminished role for the Lewy body. Parkinsonism Relat Disord 15:572-575
88. Linazasoro G (2007) Classical Parkinson disease versus Parkinson complex-reflections against staging and in favour of heterogeneity. Eur J Neurol 14:721-728
89. Lippa CF, Fujiwara H, Mann DM et al (1998) Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153:1365-1370
90. Liu S, Ninan I, Antonova I et al (2004) alpha-Synuclein produces a long-lasting increase in neurotransmitter release. EMBO J 23:4506-4516
91. Lotharius J, Brundin P (2002) Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. Hum Mol Genet 11:23952407
92. Luk KC, Song C, O'Brien P et al (2009) Exogenous alphasynuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci USA 106:20051-20056
93. Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804-2815
94. Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol 100:285-290
95. McBride PA, Schulz-Schaeffer WJ, Donaldson M et al (2001) Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. J Virol 75:9320-9327
96. McKeith I (2007) Dementia with Lewy bodies. In: Koller WC, Melamed E (eds) Parkinson's disease and related disorders, Part II. Handb Clin Neurol 84:531-548
97. McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9:417-423
98. McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863-1872
99. McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113-1124
100. McNeill TH, Brown SA, Rafols JA, Shoulson I (1988) Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res 455:148-152
101. Meissner B, Westner IM, Kallenberg K et al (2005) Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VVl type. Neurology 65:1544-1550
102. Meyer-Luehmann M, Coomaraswamy J, Bolmont T et al (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781-1784
103. Miake H, Mizusawa H, Iwatsubo T, Hasegawa M (2002) Biochemical, characterization of the core structure of alphasynuclein filaments. J Biol Chem 277:19213-19219
104. Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathology assessment of Alzheimer's disease. Neurology 41:479-486
105. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20:3214-3220
106. Nagerl UV, Eberhorn N, Cambridge SB, Bonhoeffer T (2004) Bidirectional activity-dependent morphological plasticity in hippocampal neurons. Neuron 44:759-767
107. Nakajo S, Shioda S, Nakai Y, Nakaya K (1994) Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization. Brain Res Mol Brain Res 27:81-86
108. Nakajo S, Tsukada K, Omata K, Nakamura Y, Nakaya K (1993) A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. Eur J Biochem 217:1057-1063
109. Naoi M, Maruyama W, Yi H, Inaba K, Akao Y, Shamoto-Nagai M (2009) Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. J Neural Transm 116:1371-1381
110. Nikolaus S, Antke C, Muller HW (2009) In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia. Behav Brain Res 204:1-31
111. Pan-Montojo F, Anichtchik O, Dening Y et al (2010) Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5:e8762
112. Parkkinen L, Kauppinen T, Pirttila T, Autere JM, Alafuzoff I (2005) Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol. 57:82-91
113. Patt S, Gertz HJ, Gerhard L, Cervos-Navarro J (1991) Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study. Histol Histopathol 6:373380
114. Polymeropoulos MH, Lavedan. C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047
115. Revuelta GJ, Rosso A, Lippa CF (2008) Neuritic pathology as a correlate of synaptic loss in dementia with Lewy bodies. Am J Alzheimers Dis Other Demen 23:97-102
116. Ritchie DL, Head MW, Ironside JW (2004) Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol. Appl Neurobiol. 30:360-368
117. Saito Y, Kawashima A, Ruberu NN et al (2003) Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644-654
118. Scheibe! ME, Scheibel AB (1978) The methods of Golgi. In: Robertson RT (ed) Neuroanatomical research techniques. Academic Press, New York, pp 89-114
119. Schulz-Schaeffer WJ, Fatzer R, Vandevelde M, Kretzschmar HA (2000) Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot. Arch Virol. Suppl 173-180
120. Schulz-Schaeffer WJ, Tschoke S, Kranefuss N et al (2000) The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 156:51-56
121. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791
122. Sidhu A, Wersinger C, Vernier P (2004) Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J 18:637-647
123. Simon-Sanchez J, Schulte C, Bras JM et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41:1308-1312
124. Small DH, Mok SS, Bornstein JC (2001) Alzheimer's disease and Abeta toxicity: from top to bottom. Nat Rev Neurosci 2:595-598
125. Solis O, Limon DI, Flores-Hernandez J, Flores G (2007) Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. Synapse 61:450-458 (Pubitemid 46559542)
126. Specht CG, Tigaret CM, Rast GF, Thalhammer A, Rudhard Y, Schoepfer R (2005) Subcellular localisation of recombinant alpha- and gamma-synuclein. Mol Cell Neurosci 28:326-334 (Pubitemid 40202593)
127. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251:205-208 (Pubitemid 28381082)
128. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839-840
129. Stephens B, Mueller AJ, Shering AF et al (2005) Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 132:741-754 (Pubitemid 40503224)
130. Terry RD (2000) Cell death or synaptic loss in Alzheimer disease. J Neuropathol Exp Neurol 59:1118-1119
131. Terry RD (2000) Do neuronal inclusions kill the cell? J Neural Transm Suppl 59:91-93
132. Terry RD, Masliah E, Salmon DP et al (1991) Physical, basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580
133. Thomzig A, Schulz-Schaeffer W, Kratzel C, Mai J, Beekes M (2004) Preclinical deposition of pathological prion protein PrPSc in muscles of hamsters orally exposed to scrapie. J Clin Invest 113:1465-1472
134. Thomzig A, Schulz-Schaeffer W, Wrede A et al. (2007) Accumulation of pathological prion protein PrPSc in the skin of animals with experimental and natural scrapie. PLoS Pathog 3:e66
135. Thomzig A, Spassov S, Friedrich M, Naumann D, Beekes M (2004) Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J Biol. Chem 279:33847-33854
136. Tompkins MM, Hill WD (1997) Contribution of somal Lewy bodies to neuronal death. Brain Res 775:24-29
137. Totterdell S, Meredith GE (2005) Localization, of alpha-synuclein to identified fibers and synapses in the normal mouse brain. Neuroscience 135:907-913
138. Tu PH, Galvin JE, Baba M et al (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 44:415-422
139. Ueda K, Fukushima H, Masliah E et al (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90:11282-11286
140. Wakabayashi K, Hayashi S, Kakita A et al (1998) Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 96:445-452 (Pubitemid 28474751)
141. Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27:494-506
142. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180-182 (Pubitemid 28331545)
143. Wanker EE, Scherzinger E, Heiser V, Sittler A, Eickhoff H, Lehrach H (1999) Membrane filter assay for detection of amyloid-like polyglutamine- containing protein aggregates. Methods Enzymol 309:375-386
144. Weisman D, Cho M, Taylor C, Adame A, Thai LJ, Hansen LA (2007) In dementia with Lewy bodies, Braak. stage determines phenotype, not Lewy body distribution. Neurology 69:356-359
145. Wemheuer WM, Benestad SL, Wrede A et al (2009) Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types. Am J Pathol 175:2566-2573
146. Wemheuer WM, Benestad SL, Wrede A et al (2009) Detection of classical and atypical./Nor98 scrapie by the paraffin-embedded tissue blot method. Vet Rec 164:677-681
147. Whittaker VP (1993) Thirty years of synaptosome research. J Neurocytol 22:735-742
148. Winklhofer KF, Haass C (2010) Mitochondrial dysfunction in Parkinson's disease. Biochim Biophys Acta 1802:29-44
149. Winklhofer KF, Hartl FU, Tatzelt J (2001) A sensitive filter retention assay for the detection of PrP(Sc) and the screening of anti-prion compounds. FEBS Lett 503:41-45
150. Withers GS, George JM, Banker GA, Clayton DF (1997) Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons. Brain Res Dev Brain Res 99:87-94
151. Yavich L, Tanila H, Vepsalainen S, Jakala P (2004) Role of alpha-synuclein in presynaptic dopamine recruitment. J Neurosci 24:11165-11170
152. Yu S, Li X, Liu G et al (2007) Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145:539-555
153. Yuste R, Bonhoeffer T (2001) Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci 24:1071-1089
154. Zaja-Milatovic S, Keene CD, Montine KS, Leverenz JB, Tsuang D, Montine TJ (2006) Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology 66:1591-1593 (Pubitemid 43958566)
155. Zaja-Milatovic S, Milatovic D, Schantz AM et al (2005) Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 64:545-547 (Pubitemid 40189880)
156. Zarranz JJ, Alegre J, Gomez-Esteban JC et al (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164-173 (Pubitemid 38166992)
157. Zhong SC, Luo X, Chen XS et al (2010) Expression and subcellular location of alpha-synuclein during mouse-embryonic development. Cell Mol Neurobiol 30:469-482